| PID | Disease_Kinds | Biomarker | FullName | Category | Biomarker_Type | PMID |
|---|---|---|---|---|---|---|
| 58 | Latent HF | NT-proBNP | N-terminal pro-brain natriuretic peptide | protein | Diagnosis | 27860152 |
| 247 | Drug-Refractory HF | (99m)Tc-TF | (99m)Tc-tetrofosmin | Image | Prognosis | 24977350 |
| 393 | Moderately symptomatic HF | BNP | Brain natriuretic peptide | protein | Prognosis | 20573993 |
| 493 | Transient HF | BNP | Brain natriuretic peptide | protein | Diagnosis | 19962485 |
| 494 | Transient HF | TDI | Tissue Doppler images | Image | Diagnosis | 19962485 |
| 902 | Incident HF | BNP | B-type natriuretic peptide | protein | Prognosis | 20600420 |
| 988 | Post-infarction HF | AGE | Advanced glycation end products | Molecule | Prognosis | 22909322 |
| 989 | Post-infarction HF | NT-proBNP | N-terminal pro-brain natriuretic protein | protein | Prognosis | 22909322 |
| 1008 | Severe HF | TnI | Troponin I | protein | Diagnosis | 19640280 |
| 1009 | Severe HF | IL-6 | Interleukin-6 | protein | Diagnosis | 19640280 |
| 1010 | Severe HF | TNF-α | Tumor necrosis factor-alpha | protein | Diagnosis | 19640280 |
| 1011 | Severe HF | sFas | Soluble Fas | protein | Diagnosis | 19640280 |
| 1012 | Severe HF | sFas-L | Soluble Fas-ligand | protein | Diagnosis | 19640280 |
| 1029 | Destabilized HF | ST2 | Suppression of tumorigenicity-2 | protein | Prognosis,Treatment | 18995177 |
| 1030 | Destabilized HF | BNP | B-type natriuretic peptide | protein | Prognosis,Treatment | 18995177 |
| 1031 | Destabilized HF | NT-proBNP | N-terminal pro-brain natriuretic protein | protein | Prognosis,Treatment | 18995177 |
| 1039 | Stable HF | PICP | Procollagen type I carboxyterminal propeptide | Molecule | Treatment | 23067911 |
| 1040 | Stable HF | PIIINP | Procollagen type III aminoterminal peptide | Molecule | Treatment | 23067911 |
| 1041 | Stable HF | MMP-9 | Matrix metalloproteinase 9 | protein | Treatment | 23067911 |
| 1042 | Stable HF | TIMP-1 | Tissue inhibitor of matrix metalloproteinase-1 | protein | Treatment | 23067911 |
| 1228 | Inotrope-dependent HF | BNP | B-type natriuretic peptide | protein | Diagnosis | 15848333 |
| 1229 | Inotrope-dependent HF | E-selectin | E-selectin | protein | Diagnosis | 15848333 |
| 1230 | Inotrope-dependent HF | BNP+E-selectin | B-type natriuretic peptide+E-selectin | protein | Diagnosis | 15848333 |
| 1253 | Moderate HF | cTnI | Cardiac troponin I | protein | Prognosis | 12177656 |
| 1369 | Severe HF | NT-proBNP | N-terminal pro-brain natriuretic peptide | protein | Diagnosis | 25014756 |
| 1370 | Severe HF | sST2 | Soluble suppression of tumorigenicity-2 | protein | Diagnosis | 25014756 |
| 1371 | Severe HF | Gal-3 | Galectin-3 | protein | Diagnosis,Treatment | 25014756 |
| 1372 | Severe HF | sST2+NT-proBNP | Soluble suppression of tumorigenicity-2+N-terminal pro-brain natriuretic peptide | protein | Treatment | 25014756 |
| 1373 | Severe HF | NT-proBNP+gal3+sST2 | N-terminal pro-brain natriuretic peptide+Galectin-3+Soluble suppression of tumorigenicity-2 | protein | Treatment | 25014756 |
| 1416 | Severe HF | cTnI | Cardiac troponin I | protein | Diagnosis,Prognosis | 10930813 |
| 1495 | Symptomatic HF | Nt-proBNP | N-terminal pro-type natriuretic peptide | protein | Treatment | 17395047 |
| 1496 | Symptomatic HF | HsCRP | High-sensitivity C-reactive protein | protein | Treatment | 17395047 |
| 1497 | Symptomatic HF | Glucose | Blood glucose levels | Molecule | Treatment | 17395047 |
| 1532 | Nonischemic HF | IL-6 | Interleukin-6 | protein | Treatment | 16412856 |
| 1533 | Nonischemic HF | TNF-R2 | Tumor necrosis factor-alpha receptor 2 | protein | Treatment | 16412856 |
| 1534 | Nonischemic HF | HsCRP | High-sensitivity C-reactive protein | protein | Treatment | 16412856 |
| 1535 | Nonischemic HF | E-SOD | Erythrocyte superoxide dismutase | protein | Treatment | 16412856 |
| 1536 | Nonischemic HF | LVEF | Left ventricular ejection fraction | Image | Treatment | 16412856 |
| 1537 | Nonischemic HF | LVEDD | Left ventricular end-diastolic diameter | Image | Treatment | 16412856 |
| 1538 | Nonischemic HF | LVESD | Left ventricular end-systolic diameter | Image | Treatment | 16412856 |
| 1571 | Definitive and Imminent HF | sACE2 | Soluble Angiotensin Converting Enzyme-2 | protein | Diagnosis,Treatment | 24691269 |
| 1598 | Suspected HF | NT-proBNP | N-terminal pro-B-type natriuretic peptide | protein | Prognosis | 17719336 |
| 1599 | Suspected HF | Echocardiography | Echocardiography | Image | Prognosis | 17719336 |
| 1604 | Stable mild to moderate HF | BNP | Brain natriuretic peptide | protein | Prognosis | 11145755 |
| 1605 | Stable mild to moderate HF | EDT | Deceleration time of the E wave | Image | Prognosis | 11145755 |
| 1632 | Incident HF | LVMI | Left ventricular mass index | Image | Diagnosis | 18204091 |
| 1633 | Incident HF | LVM | Excess of left ventricular mass | Image | Diagnosis | 18204091 |
| 1738 | Suspected HF | BNP | Brain natriuretic peptide | protein | Prognosis | 16973805 |
| 1753 | Mild to moderate HF | HRV(LF+rMSSD+pNN50)+BRS+MIBG | Heart rate variability(Low frequency+rMSSD+pNN50)+Baroreflex sensitivity+Metaiodobenzylguanidine | Physiology+Physiology(ECG) | Prognosis | 19662346 |
| 1754 | Mild to moderate HF | BRS | Baroreflex sensitivity | Physiology(ECG) | Prognosis | 19662346 |
| 1755 | Mild to moderate HF | HRV(LF) | Heart rate variability(Low frequency) | Physiology | Prognosis | 19662346 |
| 1756 | Mild to moderate HF | HRV(RMSSD) | Heart rate variability(RMSSD) | Physiology | Prognosis | 19662346 |
| 1757 | Mild to moderate HF | 123I-MIBG | 123I-metaiodobenzylguanidine | Image | Prognosis | 19662346 |
| 1812 | WHF(Worsening Heart Failure) | Lymphocyte | Lymphocyte | Cell | Prognosis | 23051949 |
| 1858 | Suspected HF | LAVI | Left atrial volume index | Image | Prognosis | 19359264 |
| 1859 | Suspected HF | LVESD | Left ventricular end systolic diameter | Image | Prognosis | 19359264 |
| 1891 | Severe HF | Creatinine | Creatinine | Molecule | Prognosis | 22484979 |
| 1961 | Suspected HF | QT | QT Interval | Physiology(ECG) | Prognosis | 27225136 |
| 2007 | New-onset HF | STD | ST depression | Physiology(ECG) | Diagnosis | 17599448 |
| 2057 | Suspected HF | Creatinine | Creatinine | Molecule | Prognosis | 18789548 |
| 2058 | Suspected HF | Sodium | Sodium | Molecule | Prognosis | 18789548 |
| 2059 | Suspected HF | Hb | Haemoglobin | protein | Prognosis | 18789548 |
| 2278 | Stable HF | NE | Norepinephrine | Molecule | Prognosis | 29154422 |
| 2279 | Stable HF | 123I-MIBG(H/M) | The heart to mediastinum ratio of 123I-metaiodobenzylguanidine uptake | Image | Prognosis | 29154422 |
| 2280 | Stable HF | HR | Heart rate | Physiology | Prognosis | 29154422 |
| 2302 | Non-ischaemic(mainly hypertension,diabetes and obesity) SBHF(Stage B Heart Failure) | GLS | Global longitudinal strain | Image | Diagnosis | 29154431 |
| 2303 | Non-ischaemic(mainly hypertension,diabetes and obesity) SBHF(Stage B Heart Failure) | minSTV5V6 | ST depression in lead V5 V6 | Physiology(ECG) | Diagnosis | 29154431 |
| 2304 | Non-ischaemic(mainly hypertension,diabetes and obesity) SBHF(Stage B Heart Failure) | Cornell-P | Cornell product | Image | Diagnosis | 29154431 |
| 2374 | WHF(Worsening Heart Failure) | FGF-23 | Fibroblast growth factor 23 | protein | Prognosis,Treatment | 29306478 |
| 2413 | ACHD-HF(Adult Congenital Heart Disease-Heart Failure) | BNP | Brain natriuretic protein | protein | Prognosis | 29103857 |
| 2414 | ACHD-HF(Adult Congenital Heart Disease-Heart Failure) | Sodium | Sodium | Molecule | Prognosis | 29103857 |
| 2562 | Drug-refractory HF | (99m)Tc-TF | (99m)Tc-tetrofosmin myocardial scintigraphy | Image | Treatment | 24977350 |
| 2606 | New-onset HF | STV | Myocardial segmental thickness variability | Image | Prognosis | 30594979 |
| 2607 | Severe HF | Hs-TnT | High-sensitive troponin T | protein | Prognosis | 30191296 |
| 2608 | Severe HF | Mixed SO2 | Mixed venous O2-saturation | Physiology | Prognosis | 30191296 |